EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Priming with interleukin‐1α and chemical hypoxia modulates the mesenchymal stem cell secretome to dampen microglial inflammation and promote neuroprotection

Maryam Adenike Salaudeen, Stuart M Allan, Emmanuel Pinteaux

British Journal of Pharmacology · 2026-09 · 183 (17) · 5355-5371

DOI: 10.1111/bph.70527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 09.06.2026. Verfasst von Maryam Adenike Salaudeen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Interleukin-1alpha, Microglia, Inflammation. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ahmadu Bello University Doctoral Fellowship Award, University of Manchester President Doctoral Scholarship Scheme, Ahmadu Bello University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose We hypothesised that dual priming of human bone marrow‐derived human mesenchymal stem cells (hBMSCs) with interleukin‐1alpha (IL‐1α) and CoCl 2 (a hypoxia mimetic) would modulate their therapeutic efficacy for hypoxic‐ischaemic conditions. Experimental Approach hBMSCs were primed individually or in combination. To test the anti‐inflammatory and cytoprotective properties, primed‐hBMSCs‐derived conditioned media (CM) was applied to lipopolysaccharide (LPS)‐treated BV2 microglial cells (inflammation model) and BV2 cells exposed to oxygen glucose deprivation (OGD) (hypoxic injury model). The neuroprotective effect was evaluated by assessing neuronal death (using neuron‐like cells [NLCs]) following exposure to OGD/reoxygenation (OGD/R) in the presence of various CMs. Key Results Priming significantly altered hBMSCs' secretion profiles. IL‐1α triggered significant ( P < 0.05 ) release of inflammatory mediators/cytokines, notably TNF‐α, ICAM‐1 and G‐CSF. Except for G‐SCF, dual‐priming did not potentiate their release. While single priming with either IL‐1α or hypoxia‐mimetic did not induce remarkable secretion of the neurotrophins β‐NGF and BDNF, the dual‐priming caused a potentiated increase ( P < 0.05 ) in the secretion of these neurotrophins. In the LPS model, CM from dual‐primed hBMSCs significantly reduced the secretion of pro‐inflammatory cytokines, TNF‐α and IL‐6. In the OGD/R model, priming did not significantly influence the marked reduction ( P < 0.05 ) of pro‐inflammatory cytokines IL‐1β, IL‐6 and TNF‐α. Lastly, CMs from primed hBMSCs reduced neuronal cytotoxicity, yet only CM from dual‐primed hBMSCs significantly ( P < 0.05 ) restored metabolic activity in NLCs following OGD/R. Conclusions and Implications These findings highlight dual priming as a promising strategy for optimising MSC‐based approaches for hypoxic–ischaemic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsInterleukin-1alphaMicrogliaInflammationNeuroprotectionCobaltSecretomeNeuroprotective AgentsHumansAnimalsCell HypoxiaCells, CulturedLipopolysaccharidesMiceCulture Media, Conditioned

Stichwörter der Autor:innen

cytoprotectiondual priminginflammationischaemia/reperfusion injurymesenchymal stem cellssecretometherapeutic potential

Substanzen

Interleukin-1alphaCobaltcobaltous chlorideLipopolysaccharidesNeuroprotective AgentsCulture Media, Conditioned

Autor:innen und Institutionen

  • Division of Neuroscience, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, UK.
  • Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
  • Department of Pharmacology and Therapeutics, Ahmadu Bello University, Zaria, Nigeria.

Förderung

  • Ahmadu Bello University Doctoral Fellowship Award
  • University of Manchester President Doctoral Scholarship Scheme
  • Ahmadu Bello University

Zitieren

APA

Salaudeen, M. A., Allan, S. M., & Pinteaux, E. (2026). Priming with interleukin‐1α and chemical hypoxia modulates the mesenchymal stem cell secretome to dampen microglial inflammation and promote neuroprotection. British Journal of Pharmacology, 183(17), 5355-5371. https://doi.org/10.1111/bph.70527

Vancouver

Salaudeen MA, Allan SM, Pinteaux E. Priming with interleukin‐1α and chemical hypoxia modulates the mesenchymal stem cell secretome to dampen microglial inflammation and promote neuroprotection. British Journal of Pharmacology. 2026;183(17):5355-5371. doi:10.1111/bph.70527

BibTeX
@article{Salaudeen2026,
  author = {Salaudeen, Maryam Adenike and Allan, Stuart M and Pinteaux, Emmanuel},
  title = {Priming with interleukin‐1α and chemical hypoxia modulates the mesenchymal stem cell secretome to dampen microglial inflammation and promote neuroprotection},
  journal = {British Journal of Pharmacology},
  year = {2026},
  volume = {183},
  number = {17},
  pages = {5355--5371},
  doi = {10.1111/bph.70527}
}
Kostenlos starten →